Targeting Eya2 to Inhibit c-Myc driven Medulloblastoma Tumor Progression |
University of Colorado Denver |
The Swifty Foundation |
Bad Influence: EWS/FLI Alters LSD1 and NuRD Interactions to Enforce Oncogenic Function in Ewing’s |
Research Institute at Nationwide Children's Hospital |
Northwestern Mutual Foundation |
Role of Kindlin-3 In Natural Killer Cell Mediated Tumor Killing |
Children’s Hospital of Wisconsin - Milwaukee |
Northwestern Mutual Foundation |
Pre-clinical Evaluation of LSD1 Inhibitors for the Treatment of Pediatric Ewing sarcoma: Defining the Biomarkers of Sensitivity and Mechanisms of Resistance |
Research Institute at Nationwide Children's Hospital |
Flashes of Hope |
Single-cell RNA-seq Profiling of Transcriptional Transition States During Human Retinoblastoma |
Children’s Hospital Los Angeles |
Northwestern Mutual Foundation |
Genetically Engineered T Cells as Therapy for Pediatric Glioma |
Baylor College of Medicine |
Northwestern Mutual Foundation |
Molecular Basis of ALK Inhibition Resistance in High-risk Neuroblastoma |
Dana-Farber Cancer Institute |
Northwestern Mutual Foundation |
The Role of MiRNA Impairment in Wilms' Tumor Formation |
University of Texas Southwestern Medical Center at Dallas |
Sydney Harper Foundation |
Developing Targeted Immunotherapy Against Pediatric Acute Myeloid Leukemia |
Fred Hutchinson Cancer Research Center |
I Care I Cure |
Validating a Mouse Model of Alveolar Rhabdomyosarcoma |
Duke University |
Northwestern Mutual Foundation |